Paratek Pharmaceuticals, Inc. posts $63.57 million annual profit

Paratek Pharmaceuticals, Inc. [PRTK]  has posted annual profit of $63.57 million for the year ended Dec 31,2022.

The company based in Massachusetts(MA)reported a risein revenue to $160.27 milion for the year when compared to $130.16 million in the previous year.

A filing from the company with the Securities and Exchange Commission on Mar 16,2023 showed that its revenue is  up 23.13% year-over-year.

The company reported basic earnings per share of $54387880 and diluted earnings per share of $54387880.

Paratek Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations sector.